Clear Creek Bio
Cambridge
About Clear Creek Bio
Clear Creek Bio develops therapies that target nucleotide synthesis to overcome differentiation blockade in cancer and suppress replication of RNA-based viruses. It does so using pharmacodynamic markers to ensure that each patient gets the right drug at the right dose. Our founders are leaders in cancer and stem cell biology with deep drug development and entrepreneurial experience.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $6.1M
- Last round: Series Unknown (May 2018)
- Website: clearcreekbio.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/clear-creek-bio-26829 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.